Endometrial Cancer Characteristics and Risk of Recurrence
Authors:
- 31 August 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 157 (1) , 90-97
Abstract
Objectives: To describe clinicopathologic characteristics and survival outcomes of endometrial adenocarcinomas stratified by mismatch repair (MMR) status. Methods: Single-institution, retrospective study of all women with endometrioid adenocarcinomas treated from January 2012 through December 2017. Patients were categorized into one of three groups based on MMR testing: intact MMR expression (MMR+), probable MMR mutation (MMR–), or MLH1 hypermethylation (hMLH1+). Demographics, pathologic characteristics, recurrence rates, and survival differences were analyzed. Results: In total, 316 women were included in the analysis: 235 (74.4%) patients in the MMR+ group, 10 (3.1%) in the MMR– group, and 71 (22.5%) in the hMLH1+ group. Patients with hMLH1+ were significantly older, exhibited higher-grade histology and presence of lymphovascular space invasion, and were more likely to have received adjuvant treatment. The early stage hMLH1+ patients were more likely to recur (15.3% hMLH1+ vs 2.3% MMR+ vs 12.5% MMR–, P < .001). Hypermethylation remained a significant predictor of recurrence in multivariable analysis (odds ratio, 5.09; 95% confidence interval [CI], 1.54-16.86; P = .008). Recurrence-free survival was significantly reduced in early stage hMLH1+ (hazard ratio, 7.40; 95% CI, 2.80-21.62; P < .001). Conclusions: Women with hMLH1+ endometrial cancer have worse prognostic features and recur more frequently, even in patients traditionally considered low risk for recurrence.Keywords
This publication has 18 references indexed in Scilit:
- Mismatch repair status and clinical outcome in endometrial cancer: A systematic review and meta-analysisCritical Reviews in Oncology/Hematology, 2013
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- Mismatch repair status and outcomes after adjuvant therapy in patients with surgically staged endometrial cancerGynecologic Oncology, 2010
- Microsatellite Instability Predicts Clinical Outcome in Radiation-Treated Endometrioid Endometrial CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Mechanisms and functions of DNA mismatch repairCell Research, 2007
- Microsatellite Instability and Epigenetic Inactivation of MLH1 and Outcome of Patients With Endometrial Carcinomas of the Endometrioid TypeJournal of Clinical Oncology, 2007
- Clinicopathologic Significance of Defective DNA Mismatch Repair in Endometrial CarcinomaJournal of Clinical Oncology, 2006
- Systematic Review of Microsatellite Instability and Colorectal Cancer PrognosisJournal of Clinical Oncology, 2005
- A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group studyGynecologic Oncology, 2004